Search

Your search keyword '"atropine in the treatment of myopia (ATOM) study"' showing total 2 results
Start Over Descriptor "atropine in the treatment of myopia (ATOM) study"
2 results on '"atropine in the treatment of myopia (ATOM) study"'

1. Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia

Author

Pugazhendhi S, Ambati B, and Hunter AA

Subjects
pediatric myopia, axial elongation, myopia maculopathies, scleral remodeling, myopic foveoschisis, atropine in the treatment of myopia (atom) study, macular buckle, Ophthalmology, RE1-994
Abstract

Sangeethabalasri Pugazhendhi, 1 Balamurali Ambati, 2 Allan A Hunter 3 1PSG Institute of Medical Sciences & Research, Coimbatore, India; 2Pacific ClearVision Institute, Eugene, Oregon, USA; 3Oregon Eye Consultants, Eugene, Oregon, USACorrespondence: Allan A HunterOregon Eye Consultants, 1550 Oak St. Suite 7, Eugene, Oregon 97401, USATel +1 541-687-1927Email hunter.allan.a@gmail.comPurpose: This review discusses the etiology and pathogenesis of myopia, prevention of disease progression and worsening axial elongation, and emerging myopia treatment modalities.Introduction: Pediatric myopia is a public health concern that impacts young children worldwide and is associated with numerous future ocular diseases such as cataract, glaucoma, retinal detachment and other chorioretinal abnormalities. While the exact mechanism of myopia of the human eye remains obscure, several studies have reported on the role of environmental and genetic factors in the disease development.Methods: A review of literature was conducted. PubMed and Medline were searched for combinations and derivatives of the keywords including, but not limited to, “pediatric myopia”, “axial elongation”, “scleral remodeling” or “atropine.” The PubMed and Medline database search were performed for randomized control trials, systematic reviews and meta-analyses using the same keyword combinations.Results: Studies have reported that detection of genetic correlations and modification of environmental influences may have a significant impact in myopia progression, axial elongation and future myopic ocular complications. The conventional pharmacotherapy of pediatric myopia addresses the improvement in visual acuity and prevention of amblyopia but does not affect axial elongation or myopia progression. Several studies have published varying treatments, including optical, pharmacological and surgical management, which show great promise for a more precise control of myopia and preservation of ocular health.Discussion: Understanding the role of factors influencing the onset and progression of pediatric myopia will facilitate the development of successful treatments, reduction of disease burden, arrest of progression and improvement in future of the management of myopia.Keywords: pediatric myopia, axial elongation, myopia maculopathies, scleral remodeling, myopic foveoschisis, atropine in the treatment of myopia (ATOM) study, macular buckle

Published
2020

2. Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia

Author

Sangeethabalasri, Pugazhendhi, Balamurali, Ambati, and Allan A, Hunter

Subjects
genetic structures, axial elongation, myopic foveoschisis, macular buckle, pediatric myopia, myopia maculopathies, sense organs, Review, atropine in the treatment of myopia (ATOM) study, eye diseases, scleral remodeling
Abstract

Purpose This review discusses the etiology and pathogenesis of myopia, prevention of disease progression and worsening axial elongation, and emerging myopia treatment modalities. Introduction Pediatric myopia is a public health concern that impacts young children worldwide and is associated with numerous future ocular diseases such as cataract, glaucoma, retinal detachment and other chorioretinal abnormalities. While the exact mechanism of myopia of the human eye remains obscure, several studies have reported on the role of environmental and genetic factors in the disease development. Methods A review of literature was conducted. PubMed and Medline were searched for combinations and derivatives of the keywords including, but not limited to, “pediatric myopia”, “axial elongation”, “scleral remodeling” or “atropine.” The PubMed and Medline database search were performed for randomized control trials, systematic reviews and meta-analyses using the same keyword combinations. Results Studies have reported that detection of genetic correlations and modification of environmental influences may have a significant impact in myopia progression, axial elongation and future myopic ocular complications. The conventional pharmacotherapy of pediatric myopia addresses the improvement in visual acuity and prevention of amblyopia but does not affect axial elongation or myopia progression. Several studies have published varying treatments, including optical, pharmacological and surgical management, which show great promise for a more precise control of myopia and preservation of ocular health. Discussion Understanding the role of factors influencing the onset and progression of pediatric myopia will facilitate the development of successful treatments, reduction of disease burden, arrest of progression and improvement in future of the management of myopia.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results